Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic

NCT07417774 is registered in ClinicalTrials.gov with NuvOx LLC as lead sponsor.

NCT NCT07417774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07417774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
Lead sponsor
NuvOx LLC
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 8, 2025
Completion date
December 31, 2030
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma (gbm)